As GLP-1 therapy progresses and weight loss occurs, your provider may need to reduce or discontinue some antihypertensive medications to prevent symptomatic low blood pressure, but this decision requires medical supervision and regular blood pressure monitoring
GLP-1 and GIP are incretin hormones that stimulate insulin secretion after an oral glucose load by binding GLP-1R, but both are rapidly inactivated by the enzyme dipeptidyl peptidase-4 (DPP-4)
If you have been prescribed a GLP1 injection for the first time, the idea of self-injecting can feel daunting
As proof of concept, bariatric surgery has been associated with a decreased prevalence of obesity-related cancers, including PDAC, illustrating the key role of weight management for cancer prevention 3,4
doi: 10.1007/s40265-014-0321-6 183 ChalasaniNYounossiZLavineJECharltonMCusiKRinellaMet al